ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for alerts Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.

0A4Y Aim Immunotech Inc

0.00
0.00 (0.00%)
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Aim Immunotech Inc 0A4Y London Acción Ordinaria
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
0.00 0.00% -
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
10/4/202407:21UKREGAIM ImmunoTech Announces Positive Top-Line, Protocol-Planned..
02/4/202406:30UKREGAIM ImmunoTech Reports Fourth Quarter and Full Year 2023..
26/3/202408:05UKREGAIM ImmunoTech to Discuss Fourth Quarter and Full Year 2023..
25/3/202408:05UKREGAIM ImmunoTech Announces Publication of Positive Findings..
07/3/202407:45UKREGAIM ImmunoTech Announces Launch of CEO Corner Platform
29/2/202407:45UKREGAIM ImmunoTech Outlines Recent Progress Across Clinical..
14/2/202407:55UKREGAIM ImmunoTech Announces First Subject Dosed in the..
24/1/202408:10GLOBEAIM ImmunoTech Receives Erasmus Medical Center Ethics Board..
22/1/202407:55GLOBEAIM ImmunoTech Announces that the First Subject is Enrolled..
10/1/202407:45GLOBEAIM ImmunoTech Announces Open Enrollment for Phase 1b/2..
27/11/202308:05GLOBEAIM ImmunoTech Bolsters Intellectual Property Estate for..
15/11/202306:30GLOBEAIM ImmunoTech Reports Third Quarter 2023 Financial Results..
09/11/202307:05GLOBEAIM ImmunoTech to Discuss Third Quarter 2023 Financial..
17/10/202307:45GLOBEAIM ImmunoTech Engages Business Development Firm, Azenova,..
11/9/202312:00GLOBEAIM ImmunoTech Announces Report of Complete Topline Data..
15/8/202305:45GLOBEAIM ImmunoTech Reports Second Quarter Financial Results and..
09/8/202308:05GLOBEAIM ImmunoTech to Discuss Second Quarter 2023 Financial..
08/8/202307:05GLOBEAIM ImmunoTech Announces Completion of Enrollment in Phase 2..
18/7/202318:30GLOBEAIM ImmunoTech Issues Notice that an Unaffiliated Third..
10/7/202307:05GLOBEAIM ImmunoTech Enrolls and Doses First Subject in Phase 2..
27/6/202310:16GLOBEAIM ImmunoTech Announces Publication of Positive Findings..
27/6/202307:45GLOBEAIM ImmunoTech Announces Authorizations from Competent..

Su Consulta Reciente

Delayed Upgrade Clock